| Descemetectomy as therapy option for visually disturbing roll in Descemet's membrane. | |
| | |
MedLine Citation:
|
PMID: 23392855 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
PURPOSE: The aim was to demonstrate the feasibility of targeted removal of a central visually disturbing roll in Descemet's membrane after complicated cataract surgery. MATERIALS AND METHODS: Case report: a 76-year-old patient complained of halos and reduced visual acuity after external cataract surgery. At slit-lamp examination a central roll in Descemet's membrane was found (2 × 2 mm). RESULTS: A targeted central descemetectomy was performed by circular descemetorhexis around the defect. Early postoperative visual acuity improved and halos disappeared. At 2 months postoperatively best corrected visual acuity (BCVA) was 1.0 and the endothelial cell count was not significantly changed. CONCLUSIONS: Central targeted descemetorhexis is a safe therapeutic option for visually disturbing defects of Descemet's membrane. |
| | |
Authors:
|
C Cursiefen; B Bachmann |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2013-2-8 |
Journal Detail:
|
Title: Der Ophthalmologe : Zeitschrift der Deutschen Ophthalmologischen Gesellschaft Volume: - ISSN: 1433-0423 ISO Abbreviation: Ophthalmologe Publication Date: 2013 Feb |
Date Detail:
|
Created Date: 2013-2-8 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9206148 Medline TA: Ophthalmologe Country: - |
Other Details:
|
Languages: GER Pagination: - Citation Subset: - |
Affiliation:
|
Zentrum für Augenheilkunde, Klinik und Poliklinik für Allgemeine Augenheilkunde, Universität zu Köln, Joseph-Stelzmann-Str. 9, 50924, Köln, Deutschland, claus.cursiefen@uk-koeln.de. |
Vernacular Title:
|
Descemetektomie als Therapieoption bei zentraler visusbeeinträchtigender Descemet-Rolle. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stage IV Melanoma: Completely Resectable Patients are Scarce.
Next Document: Flos Lonicerae Extracts and Chlorogenic Acid Protect Human Umbilical Vein Endothelial Cells from the...